Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas Aeruginosa Arising by AmpC- And Non-AmpC-Mediated Pathways”

Case Reports in Infectious Diseases
doi 10.1155/2019/8314349

Related search